Advances in Therapy

, Volume 24, Issue 6, pp 1210–1220 | Cite as

Effect of insulin sensitivity on SHBG levels in premenopausal versus postmenopausal obese women

  • Fulya AkinEmail author
  • Mehmet Bastemir
  • Esma Alkis


This study was performed to evaluate the impact of insulin sensitivity on sex hormone-binding globulin (SHBG) and sex steroids in premenopausal and postmenopausal euthyroid obese women. A total of 227 women were eligible for this study. All were euthyroid, obese, and overweight; ages ranged from 25 to 69 years. Women were divided into premenopausal (n=151) and postmenopausal (n=76) groups. SHBG, sex steroids, thyrotropin, fasting and postprandial glucose, lipid profile, uric acid, serum insulin, and blood pressure were measured. No significant difference was found in mean SHBG levels between premenopausal and postmenopausal women. The investigators observed that during transition from premenopause to postmenopause, SHBG levels increased in insulin-sensitive women in the postmenopausal group; however, SHBG levels decreased in insulinresistant women. It was concluded that SHBG blood concentration factors are likely to change during transition from premenopause to postmenopause. The positive effect of estradiol on SHBG levels is probably stronger in premenopausal women than in postmenopausal women. It has been noted that after menopause, the impact of insulin resistance on SHBG level seems more important than the effect of estradiol.


SHBG premenopause postmenopause obesity insulin sensitivity sex steroids 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hammond GL. Molecular properties of corticosteroid binding globulins and the sex-steroid binding proteins.Endocr Rev. 1990;17:65–79.Google Scholar
  2. 2.
    Rosner W. The functions of corticosteroid-binding globulin and sex hormone—binding globulin: recent advances.Endocr Rev. 1990;17:80–91.Google Scholar
  3. 3.
    Selby C. Sex hormone—binding globulin: origin, function and clinical significance.Ann Clin Biochem. 1990;27:532–541.PubMedGoogle Scholar
  4. 4.
    Schoultz B, Carlström K. On the regulation of sex hormone binding globulin: a challenge of an old dogma and outlines of an alternative mechanism.J Steroid Biochem Mol Biol. 1989;32:327–334.Google Scholar
  5. 5.
    Toscano V, Balducci R, Bianchi P, Guglielmi R, Mangiantini A, Sciarra F. Steroidal and non-steroidal factors in plasma sex hormone-binding globulin regulation.J Steroid Biochem Mol Biol. 1992;43:431–437.PubMedCrossRefGoogle Scholar
  6. 6.
    Pasquali R, Vicennati V, Bertazzo D, et al, for the Virgilio Menopause Health Group. Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status.Metabolism. 1997;46:5–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Loukovaara M, Carson M, Adlercreutz H. Regulation of production and secretion of sex hormone-binding globulin in HepG2 cell cultures by hormones and growth factors.J Clin Endocrinol Metab. 1995;80:160–164.PubMedCrossRefGoogle Scholar
  8. 8.
    Plymate SR, Matej LA, Jones RE, Friedl K. Inhibition of sex hormone-binding globulin production in the human hepatoma (HepG2) cell line by insulin and prolactin.J Clin Endocrinol Metab. 1988;67:460–464.PubMedCrossRefGoogle Scholar
  9. 9.
    Meirow D, Yossepowitch O, Rosler A, et al. Insulin resistant and non-resistant polycystic ovary syndrome represent two clinical and endocrinological subgroups.Hum Reprod. 1995;10:1951–1956.PubMedGoogle Scholar
  10. 10.
    Pasquali R, Casimirri F, Cantobelli S, et al. Effect of obesity and body fat distribution on sex hormones and insulin in men.Metabolism. 1991;40:101–104.PubMedCrossRefGoogle Scholar
  11. 11.
    Lindstedt G, Lundberg PA, Lapidus L, Lundgren H, Bengtsson C, Bjorntorp P. Low sex-hormone- binding globulin concentration as independent risk factor for development of NIDDM: 12-yr follow-up of population study of women in Gothenburg, Sweden.Diabetes. 1991;40:123–128.PubMedCrossRefGoogle Scholar
  12. 12.
    Tchernof A, Despres JP. Sex steroid hormones, sex hormone-binding globulin, and obesity in men and women.Horm Metab Res. 2000;32:526–536.PubMedGoogle Scholar
  13. 13.
    Haffner SM, Katz MS, Dunn JF. Increased upper body and overall adiposity is associated with decreased sex hormone binding globulin in postmenopausal women.Int J Obes. 1991;15:471–478.PubMedGoogle Scholar
  14. 14.
    Pugeat M, Moulin P, Cousin P, et al. Interrelations between sex hormone-binding globulin (SHBG), plasma lipoproteins and cardiovascular risk.J Steroid Biochem Mol Biol. 1995;53:567–572.PubMedCrossRefGoogle Scholar
  15. 15.
    Hajamor S, Despres JP, Couillard C, Lemieux S, Tremblay A, Prud’homme D. Relationship between sex hormone—binding globulin levels and features of the metabolic syndrome.Metabolism. 2003;52:724–730.PubMedCrossRefGoogle Scholar
  16. 16.
    Lukanova A, Lundin E, Jacquette AZ, et al. Body mass index, circulating levels of steroid hormones, IGF-1 and IGF-binding protein-3: a cross-sectional study in healthy women.Eur J Endocrinol. 2004;150:161–171PubMedCrossRefGoogle Scholar
  17. 17.
    Pasquali R, Casimirri F, Pascal G. Influence of menopause on blood cholesterol levels in women: the role of body composition, fat distribution and hormonal milieu. Virgilio Menopause Health Group.J Intern Med. 1997;241:195–203.PubMedCrossRefGoogle Scholar
  18. 18.
    Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.Diabetologia. 1985;28:412–419.PubMedCrossRefGoogle Scholar
  19. 19.
    Odell WD. The menopause. In: DeGroot LJ, ed.Endocrinology. Philadelphia, Pa: WB Saunders; 1989:2009–2018.Google Scholar
  20. 20.
    Lebovitz HE. Insulin resistance and the insulin resistance syndrome. In:Clinician’s Manual on Insulin Resistance. London, England: Science Press; 2002:1–15.Google Scholar
  21. 21.
    Metabolic consequences of overweight, underweight and physical activity/inactivity. In: Vainio H, Bianchini F, eds.Weight Control and Physical Activity. 1st ed. Lyon, France: IARC Press; 2002:53–82.Google Scholar
  22. 22.
    Key TJ, Allen NE, Verkaslo PK, Banks E. Energy balance and cancer: the role of sex hormones.Proc Nutr Soc. 2001;60:81–89.PubMedGoogle Scholar
  23. 23.
    Kaaks R, Lukanova A. Energy balance and cancer: the role of insulin and insulin-like growth factor-1.Proc Nutr Soc. 2001;60:91–106.PubMedGoogle Scholar
  24. 24.
    Endre T, Mattiasson I, Berglund G, Hulthen UL. Low testosterone and insulin resistance in hypertension-prone men.J Hum Hypertens. 1996;10:755–761.PubMedGoogle Scholar

Copyright information

© Health Communications Inc 2007

Authors and Affiliations

  1. 1.Endokrinoloji ve Metabolizma HastaliklariPamukkale ÜniversitesiDenizliTurkey
  2. 2.Department of Public Health Faculty of MedicinePamukkale UniversityDenizliTurkey

Personalised recommendations